Senator Bill Cassidy pushes back on witnesses, warning about negative effects of a government monopsony on pharmaceuticals and dangers to investment and invention.
Stay Connected
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com
Bill Cassidy argues against “unilateral” government control on drug pricing